Table 3.

Changes in polyp size and number over the course of treatment and FMO3 genotypes in the study patients

PatientPolyp size (mm)
Polyp number
FMO3 genotype
Baseline3 months6 monthsBaseline3 months6 monthsE158KE308GClass
152.61.2744WT/PWT/P1
231.9121168P/PWT/P1
35.54.52160160160WT/PWT/WT2
41.70.40.6812WT/PWT/WT2
532.32.9342729WT/WTWT/WT2
61.51.31.87814WT/WTWT/WT2
71.73.52.1211114P/PWT/WT2
841.10.62051WT/PWT/P1
9330.61063WT/PWT/WT2
102.81.10.11283P/PWT/WT2
112.82.51.216166WT/PWT/WT2
122.4NA0.41933WT/WTWT/WT2
132.50.614776P/PWT/P1
143.100700WT/WTWT/WT2
152.8001800P/PWT/P1
162.2001000P/PWT/WT2
172.1001600WT/PWT/WT2
183.82.73.6803040WT/PWT/WT2
196.22.32.8802212WT/PWT/P1